Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

WHAT'S NEW

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Aug 25 2020

Full Issue

EPA Approves Use Of Long-Lasting COVID Disinfectant In Texas

Texas sought emergency approval from the EPA for the use of SurfaceWise2. Texas-based American Airlines and two branches of Total Orthopedics Sports & Spine will now be able to use it.

The Washington Post: EPA Approves Cleanser For Use Against Covid19 

The Environmental Protection Agency gave emergency approval Monday for the application of a cleanser intended to kill the novel coronavirus on surfaces for up to seven days, and the state of Texas said it would allow American Airlines and two branches of Total Orthopedics Sports & Spine to start using the new product. The agency said it hoped the product — called SurfaceWise2 and made by Allied BioScience — would provide longer-lasting protection in public spaces and increase consumer confidence in air travel, which has suffered a big hit during the covid-19 pandemic. (Mufson, 8/24)

ABC News: American To Spray Some Planes With EPA-Approved 'Long-Lasting' COVID-19 Disinfectant 

The EPA granted emergency authorization for the Allied BioScience product, Surfacewise 2, on Monday. It is effective against the SARS-CoV2 virus for up to 7 days after a single application, according to testing by the agency. Texas had requested the authorization. “SurfaceWise2 creates an invisible barrier on surfaces, which physically breaks down and kills virus cells,” said Dr. Charles Gerba, an infectious disease expert who works with Allied BioScience. (Ebbs and Kaji, 8/24)

In other travel safety news —

MarketWatch: Report Card: Which Hotel Brands Have Adapted Best To COVID-19? 

The COVID-19 pandemic has turned travel upside down, and the hotel industry has been forced to cope with a constantly changing landscape of traveler expectations. From new cancellation policies to improved cleaning and social distancing procedures, major hotel brands have scrambled to adapt to the new reality. But which hotel brands have adapted best? Which have offered the most customer-friendly policies and been willing to sacrifice bottom-line concerns for the sake of guest safety? (Kemmis, 8/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 12
  • Monday, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF